Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

C. Graux, M. Stevens-Kroef, M. Lafage, N. Dastugue, C. J. Harrison, F. Mugneret, K. Bahloula, S. Struski, M. J. Grégoire, N. Nadal, E. Lippert, S. Taviaux, A. Simons, R. P. Kuiper, Anthony Moorman, K. Barber, A. Bosly, L. Michaux, P. Vandenberghe, I. LahortigaK. De Keersmaecker, I. Wlodarska, J. Cools, A. Hagemeijer, H. A. Poirel

Research output: Contribution to journalArticle

Abstract

Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric study we collected 27 cases of NUP214-ABL1-positive T-ALL. Median age was 15 years with male predominance. Outcome was poor in 12 patients. An associated abnormality involving TLX1 or TLX3 was found in all investigated cases. Fluorescent in situ hybridization revealed a heterogeneous pattern of NUP214-ABL1 amplification. Multiple episomes carrying the fusion were detected in 24 patients. Episomes were observed in a significant number of nuclei in 18 cases, but in only 1-5% of nuclei in 6. In addition, intrachromosomal amplification (small hsr) was identified either as the only change or in association with episomes in four cases and two T-ALL cell lines (PEER and ALL-SIL). One case showed insertion of apparently non-amplified NUP214-ABL1 sequences at 14q12. The amplified sequences were analyzed using array-based CGH. These findings confirm that the NUP214-ABL1 gene requires amplification for oncogenicity; it is part of a multistep process of leukemogenesis; and it can be a late event present only in subpopulations. Data also provide in vivo evidence for a model of episome formation, amplification and optional reintegration into the genome. Implications for the use of kinase inhibitors are discussed.

Original languageEnglish (US)
Pages (from-to)125-133
Number of pages9
JournalLeukemia
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Gene Fusion
Plasmids
Gene Amplification
Fluorescence In Situ Hybridization
Phosphotransferases
Genome
Cell Line

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Graux, C., Stevens-Kroef, M., Lafage, M., Dastugue, N., Harrison, C. J., Mugneret, F., ... Poirel, H. A. (2009). Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia, 23(1), 125-133. https://doi.org/10.1038/leu.2008.278

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. / Graux, C.; Stevens-Kroef, M.; Lafage, M.; Dastugue, N.; Harrison, C. J.; Mugneret, F.; Bahloula, K.; Struski, S.; Grégoire, M. J.; Nadal, N.; Lippert, E.; Taviaux, S.; Simons, A.; Kuiper, R. P.; Moorman, Anthony; Barber, K.; Bosly, A.; Michaux, L.; Vandenberghe, P.; Lahortiga, I.; De Keersmaecker, K.; Wlodarska, I.; Cools, J.; Hagemeijer, A.; Poirel, H. A.

In: Leukemia, Vol. 23, No. 1, 01.01.2009, p. 125-133.

Research output: Contribution to journalArticle

Graux, C, Stevens-Kroef, M, Lafage, M, Dastugue, N, Harrison, CJ, Mugneret, F, Bahloula, K, Struski, S, Grégoire, MJ, Nadal, N, Lippert, E, Taviaux, S, Simons, A, Kuiper, RP, Moorman, A, Barber, K, Bosly, A, Michaux, L, Vandenberghe, P, Lahortiga, I, De Keersmaecker, K, Wlodarska, I, Cools, J, Hagemeijer, A & Poirel, HA 2009, 'Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia', Leukemia, vol. 23, no. 1, pp. 125-133. https://doi.org/10.1038/leu.2008.278
Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison CJ, Mugneret F et al. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia. 2009 Jan 1;23(1):125-133. https://doi.org/10.1038/leu.2008.278
Graux, C. ; Stevens-Kroef, M. ; Lafage, M. ; Dastugue, N. ; Harrison, C. J. ; Mugneret, F. ; Bahloula, K. ; Struski, S. ; Grégoire, M. J. ; Nadal, N. ; Lippert, E. ; Taviaux, S. ; Simons, A. ; Kuiper, R. P. ; Moorman, Anthony ; Barber, K. ; Bosly, A. ; Michaux, L. ; Vandenberghe, P. ; Lahortiga, I. ; De Keersmaecker, K. ; Wlodarska, I. ; Cools, J. ; Hagemeijer, A. ; Poirel, H. A. / Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. In: Leukemia. 2009 ; Vol. 23, No. 1. pp. 125-133.
@article{7e26a01d1d2f40bfb5bc920871df71b8,
title = "Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia",
abstract = "Episomes with the NUP214-ABL1 fusion gene have been observed in 6{\%} of T-ALL. In this multicentric study we collected 27 cases of NUP214-ABL1-positive T-ALL. Median age was 15 years with male predominance. Outcome was poor in 12 patients. An associated abnormality involving TLX1 or TLX3 was found in all investigated cases. Fluorescent in situ hybridization revealed a heterogeneous pattern of NUP214-ABL1 amplification. Multiple episomes carrying the fusion were detected in 24 patients. Episomes were observed in a significant number of nuclei in 18 cases, but in only 1-5{\%} of nuclei in 6. In addition, intrachromosomal amplification (small hsr) was identified either as the only change or in association with episomes in four cases and two T-ALL cell lines (PEER and ALL-SIL). One case showed insertion of apparently non-amplified NUP214-ABL1 sequences at 14q12. The amplified sequences were analyzed using array-based CGH. These findings confirm that the NUP214-ABL1 gene requires amplification for oncogenicity; it is part of a multistep process of leukemogenesis; and it can be a late event present only in subpopulations. Data also provide in vivo evidence for a model of episome formation, amplification and optional reintegration into the genome. Implications for the use of kinase inhibitors are discussed.",
author = "C. Graux and M. Stevens-Kroef and M. Lafage and N. Dastugue and Harrison, {C. J.} and F. Mugneret and K. Bahloula and S. Struski and Gr{\'e}goire, {M. J.} and N. Nadal and E. Lippert and S. Taviaux and A. Simons and Kuiper, {R. P.} and Anthony Moorman and K. Barber and A. Bosly and L. Michaux and P. Vandenberghe and I. Lahortiga and {De Keersmaecker}, K. and I. Wlodarska and J. Cools and A. Hagemeijer and Poirel, {H. A.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1038/leu.2008.278",
language = "English (US)",
volume = "23",
pages = "125--133",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

AU - Graux, C.

AU - Stevens-Kroef, M.

AU - Lafage, M.

AU - Dastugue, N.

AU - Harrison, C. J.

AU - Mugneret, F.

AU - Bahloula, K.

AU - Struski, S.

AU - Grégoire, M. J.

AU - Nadal, N.

AU - Lippert, E.

AU - Taviaux, S.

AU - Simons, A.

AU - Kuiper, R. P.

AU - Moorman, Anthony

AU - Barber, K.

AU - Bosly, A.

AU - Michaux, L.

AU - Vandenberghe, P.

AU - Lahortiga, I.

AU - De Keersmaecker, K.

AU - Wlodarska, I.

AU - Cools, J.

AU - Hagemeijer, A.

AU - Poirel, H. A.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric study we collected 27 cases of NUP214-ABL1-positive T-ALL. Median age was 15 years with male predominance. Outcome was poor in 12 patients. An associated abnormality involving TLX1 or TLX3 was found in all investigated cases. Fluorescent in situ hybridization revealed a heterogeneous pattern of NUP214-ABL1 amplification. Multiple episomes carrying the fusion were detected in 24 patients. Episomes were observed in a significant number of nuclei in 18 cases, but in only 1-5% of nuclei in 6. In addition, intrachromosomal amplification (small hsr) was identified either as the only change or in association with episomes in four cases and two T-ALL cell lines (PEER and ALL-SIL). One case showed insertion of apparently non-amplified NUP214-ABL1 sequences at 14q12. The amplified sequences were analyzed using array-based CGH. These findings confirm that the NUP214-ABL1 gene requires amplification for oncogenicity; it is part of a multistep process of leukemogenesis; and it can be a late event present only in subpopulations. Data also provide in vivo evidence for a model of episome formation, amplification and optional reintegration into the genome. Implications for the use of kinase inhibitors are discussed.

AB - Episomes with the NUP214-ABL1 fusion gene have been observed in 6% of T-ALL. In this multicentric study we collected 27 cases of NUP214-ABL1-positive T-ALL. Median age was 15 years with male predominance. Outcome was poor in 12 patients. An associated abnormality involving TLX1 or TLX3 was found in all investigated cases. Fluorescent in situ hybridization revealed a heterogeneous pattern of NUP214-ABL1 amplification. Multiple episomes carrying the fusion were detected in 24 patients. Episomes were observed in a significant number of nuclei in 18 cases, but in only 1-5% of nuclei in 6. In addition, intrachromosomal amplification (small hsr) was identified either as the only change or in association with episomes in four cases and two T-ALL cell lines (PEER and ALL-SIL). One case showed insertion of apparently non-amplified NUP214-ABL1 sequences at 14q12. The amplified sequences were analyzed using array-based CGH. These findings confirm that the NUP214-ABL1 gene requires amplification for oncogenicity; it is part of a multistep process of leukemogenesis; and it can be a late event present only in subpopulations. Data also provide in vivo evidence for a model of episome formation, amplification and optional reintegration into the genome. Implications for the use of kinase inhibitors are discussed.

UR - http://www.scopus.com/inward/record.url?scp=58249140126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249140126&partnerID=8YFLogxK

U2 - 10.1038/leu.2008.278

DO - 10.1038/leu.2008.278

M3 - Article

C2 - 18923437

AN - SCOPUS:58249140126

VL - 23

SP - 125

EP - 133

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -